ATI Technologies Inc. was a semiconductor technology corporation based in Markham, Ontario, Canada, that specialized in the development of graphics processing units and chipsets. Founded in 1985 as Array Technologies Industry, the company was listed publicly in 1993 and was acquired by Advanced Micro Devices in 2006. As a major fabrication-less or fabless semiconductor company, ATI conducted research and development in-house and outsourced the manufacturing and assembly of its products. ATI and its chief rival Nvidia emerged as the two dominant players in the graphics processors industry, eventually forcing other manufacturers into niche roles.The acquisition of ATI in 2006 was important to AMD's strategic development of its Fusion generation of computer processors, which integrated general processing abilities with graphics processing functions within a single chip. Since 2010, the ATI brand name is no longer used for any of AMD's graphics processor products. Wikipedia.
Holst-Jensen A.,Norwegian Veterinary Institute |
Bertheau Y.,French National Institute for Agricultural Research |
de Loose M.,Belgium Institute for Agricultural and Fisheries Research |
Grohmann L.,Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit |
And 8 more authors.
Biotechnology Advances | Year: 2012
Genetically modified plants, in the following referred to as genetically modified organisms or GMOs, have been commercially grown for almost two decades. In 2010 approximately 10% of the total global crop acreage was planted with GMOs (James, 2011). More than 30 countries have been growing commercial GMOs, and many more have performed field trials. Although the majority of commercial GMOs both in terms of acreage and specific events belong to the four species: soybean, maize, cotton and rapeseed, there are another 20. + species where GMOs are commercialized or in the pipeline for commercialization. The number of GMOs cultivated in field trials or for commercial production has constantly increased during this time period. So have the number of species, the number of countries involved, the diversity of novel (added) genetic elements and the global trade. All of these factors contribute to the increasing complexity of detecting and correctly identifying GMO derived material. Many jurisdictions, including the European Union (EU), legally distinguish between authorized (and therefore legal) and un-authorized (and therefore illegal) GMOs. Information about the developments, field trials, authorizations, cultivation, trade and observations made in the official GMO control laboratories in different countries around the world is often limited, despite several attempts such as the OECD BioTrack for voluntary dissemination of data. This lack of information inevitably makes it challenging to detect and identify GMOs, especially the un-authorized GMOs. The present paper reviews the state of the art technologies and approaches in light of coverage, practicability, sensitivity and limitations. Emphasis is put on exemplifying practical detection of un-authorized GMOs. Although this paper has a European (EU) bias when examples are given, the contents have global relevance. © 2012 Elsevier Inc. Source
Array Technologies | Date: 2013-10-02
A mounting bracket assembly comprises a flexible body including at least one top member and a flexible angled bottom member connected to the top member. The flexible body defines a beam insertion aperture between the top member and the bottom member. The mounting bracket assembly further comprises at least one clamp attached to the top member. The mounting bracket assembly may further comprise a threaded rod running through the at least one top member and a clamping nut securing the threaded rod to the top member such that rotating the clamping nut compresses the top member and grounds an electricity generating device such as a photovoltaic module. The mounting bracket assembly may further comprise an integral grounding device disposed adjacent the top member to electrically ground the electricity generating device.
Array Technologies | Date: 2014-03-04
Photovoltaic solar modules contained on racks that are fixed in an optimal position relative to the locations latitude to generate production of energy from solar light.
Array Technologies | Date: 2014-02-05
Solar trackers in the nature of photovoltaic solar modules that track the sun in order to optimize the production of energy from the solar light.
Agency: Department of Health and Human Services | Branch: | Program: STTR | Phase: Phase I | Award Amount: 99.96K | Year: 2005
DESCRIPTION (provided by applicant): Up to 3 percent of populations worldwide have psoriasis. A large number of the patients with psoriasis can be treated using UV light exposure. We propose to employ a light modulating microchip based on recent Micro Electro Mechanical Systems (MEMS) technological developments to build an Automated Psoriasis Treatment System. The overall goal of Phase I and Phase II of this proposal is to develop a working Automated Psoriasis Treatment System prototype. The device will be able to use monochromatic UVB light (308 nm) to selectively treat psoriasis lesions and minimize healthy skin exposure to UV light. In the core of the device to be developed are the Digital Micromirror Device (DMD) by Texas Instruments and a machine vision system. Specific Aims for Phase I are: 1. Design and build a prototype optical system able to project images corresponding to typical lesions. Form patterns with the DMD at 308 nm. 2. Develop prototype software controls that will be capable of producing the mask patterns, taken from lesion images, with the refresh rate of 1 Hz or better. 3. Integrate the optical system and software controls. In Phase II of the project we will complete the development of the stand-alone instrument prototype.